[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100556122":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":23,"centralContacts":37,"locations":43,"responsibleParty":60,"collaborators":64,"id":67,"slug":68,"hasResults":69,"nctId":70,"briefTitle":71,"officialTitle":71,"acronym":23,"eligibilityCriteria":72,"healthyVolunteers":73,"sex":74,"minAge":75,"maxAge":76,"enrollmentInfo":77,"targetDuration":23,"studyType":80,"phases":81,"briefSummary":83,"conditions":84,"keywords":23,"overallStatus":45,"whyStopped":23,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":97},{"fullName":5,"class":6},"University of Missouri-Columbia","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"Women","Women will be 18-70 years of age",[12,13,14,15,16],"Drug: Norepinephrine","Drug: Isoproterenol","Drug: Acetylcholine","Drug: Nitroprusside","Drug: Estrogen",[18,24,27,30,33],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":23},"DRUG","Norepinephrine","Infused intra-arterially in a dose-response fashion",[9],null,{"type":19,"name":25,"description":21,"armGroupLabels":26,"otherNames":23},"Isoproterenol",[9],{"type":19,"name":28,"description":21,"armGroupLabels":29,"otherNames":23},"Acetylcholine",[9],{"type":19,"name":31,"description":21,"armGroupLabels":32,"otherNames":23},"Nitroprusside",[9],{"type":19,"name":34,"description":35,"armGroupLabels":36,"otherNames":23},"Estrogen","Infused intra-arterially",[9],[38],{"name":39,"role":40,"phone":41,"phoneExt":23,"email":42},"Jacqueline K Limberg","CONTACT","573-882-2420","limbergj@missouri.edu",[44],{"facility":5,"status":45,"city":46,"state":47,"zip":48,"country":49,"countryCode":50,"cosmosGeoPoint":51,"geoPoint":56,"contacts":57},"RECRUITING","Columbia","Missouri","65211","United States","US",{"type":52,"coordinates":53},"Point",[54,55],-92.33407,38.95171,{"lat":55,"lon":54},[58],{"name":59,"role":40,"phone":41,"phoneExt":23,"email":42},"Jacqueline K Limberg, Ph.D.",{"type":61,"investigatorFullName":62,"investigatorTitle":63,"investigatorAffiliation":5,"oldNameTitle":23,"oldOrganization":23},"PRINCIPAL_INVESTIGATOR","Jacqueline K Limberg, PhD","Associate Professor",[65],{"name":66,"class":6},"American Heart Association","100556122","early-phase-1-early-neurovascular-adaptations-in-aging-women-100556122",false,"NCT06520982","Early Neurovascular Adaptations in Aging Women","Inclusion Criteria:\n\n* Assigned female at birth (AFAB)\n* 18-70 years of age\n\nExclusion Criteria:\n\n* Assigned male at birth (AMAB)\n* Pregnancy, breastfeeding\n* Body mass index ≥30 kg\u002Fm2\n* Taking medications known to affect metabolic, autonomic, and\u002For respiratory function\n* Oral hormonal contraception in last 6 month\n* History of hormone replacement therapy\n* History of hyster- or oophor-ectomy\n* Current smoking\u002FNicotine use\n* Increased risk of bleeding, pro-coagulant disorders, clotting disorders, anticoagulation therapy\n* Chronic disease\n* Blood pressure ≥140\u002F90 mmHg\n* Communication barriers",true,"FEMALE","18 Years","70 Years",{"count":78,"type":79},64,"ESTIMATED","INTERVENTIONAL",[82],"EARLY_PHASE1","Our goal is to enhance our understanding of early vascular adaptations in aging women with an emphasis on the sympathetic nervous system.",[9,85,86,87],"Sympathetic Nervous System","Aging","Blood Flow","2025-11-20",{"date":90,"type":91},"2025-11-26","ACTUAL",{"date":93,"type":91},"2024-09-20",{"date":95,"type":79},"2028-06-30",{"name":5,"class":6},1]